Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Healthcare Company (ACHC) Share-based Compensation (2016 - 2026)

Acadia Healthcare Company (ACHC) has disclosed Share-based Compensation for 16 consecutive years, with $8.0 million as the latest value for Q1 2026.

  • For Q1 2026, Share-based Compensation fell 8.05% year-over-year to $8.0 million; the TTM value through Mar 2026 reached $31.0 million, down 16.64%, while the annual FY2025 figure was $31.7 million, 14.53% down from the prior year.
  • Share-based Compensation hit $8.0 million in Q1 2026 for Acadia Healthcare Company, up from $6.5 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $10.5 million in Q2 2025 and bottomed at $6.0 million in Q3 2025.
  • Average Share-based Compensation over 5 years is $8.2 million, with a median of $8.0 million recorded in 2026.
  • Year-over-year, Share-based Compensation tumbled 36.88% in 2022 and then rose 21.12% in 2024.
  • Acadia Healthcare Company's Share-based Compensation stood at $7.9 million in 2022, then grew by 16.6% to $9.2 million in 2023, then rose by 9.63% to $10.1 million in 2024, then tumbled by 36.04% to $6.5 million in 2025, then increased by 24.01% to $8.0 million in 2026.
  • According to Business Quant data, Share-based Compensation over the past three periods came in at $8.0 million, $6.5 million, and $6.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.